Having trouble accessing articles? Reset your cache.

LB-100: Phase I started

Lixte began an open-label, U.S. Phase I trial

Read the full 86 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE